United Therapeutics | UTHR - Ebitda

Aktienkurs
536.12
Täglich Wechseln
3.30 0.62%
Monatlich
11.13%
Jährlich
74.50%
Q1 Prognose
519.93




Ebitda Veränderung Datum
Amarin USD 12.54M 28.57M 2025-06
Ardelyx USD 5.57M 17.44M 2025-09
Baxter International USD 426M 36M 2025-09
Bayer EUR 1.97B 457M 2025-12
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Esperion Therapeutics USD -27.51M 9.5M 2023-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Insmed USD -314.19M 31.48M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
J&J USD 9.52B 389M 2025-09
Moderna USD -790M 582M 2025-12
Omeros USD -47.96M 7.39M 2023-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD 20.63M 53.74M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
United Therapeutics USD 379.5M 83.4M 2025-12
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09